Genedata Screener 14 Raises the Bar on Efficiency and Workflow Support

Latest release improves automation and provides several innovative data analysis features

Basel, Switzerland – Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced Genedata Screener® version 14. As the leading platform for all in-vitro screening, the newest version of Genedata Screener further accelerates analysis of assays with more automation and guided workflow support. Version 14 deepens compound qualification from biological assays by providing compound-centric overviews and results across experiments, sub-experiments, assay groups, and panels. This new version also brings to market new capabilities for collaborative pharmaceutical research.

Screening Platform of Choice for More than 50% of the World’s Top 25 Pharmaceutical Research Firms

Global adoption of Genedata Screener continues to increase rapidly. Today, more than half of the world’s leading pharmaceutical companies plus some of the world’s most innovati

< | >